Literature DB >> 21701391

Barrett's, blood groups and progression to oesophageal cancer: is nitric oxide the link?

Christine P J Caygill1, Christine Royston, André Charlett, Christine M Wall, Piers A C Gatenby, James R Ramus, Anthony Watson, Marc Winslet, Christopher S Hourigan, Karna Dev Bardhan.   

Abstract

INTRODUCTION: Incidence of oesophageal adenocarcinoma (OAC) is increasing rapidly. OAC arises in columnar-lined oesophagus (CLO), a metaplastic change affecting some patients with gastro-oesophageal reflux disease (GORD). As yet there is no reliable method of identifying those at highest risk. Our earlier observation of an association between OAC and blood group O Rhesus negative, if confirmed, may help identify those at greatest risk. AIM AND METHODS: To assess the distribution of blood group and Rhesus D (RhD) factor in patients with GORD compared with the blood donating general population. GORD was categorized as nonerosive reflux (NER), erosive oesophagitis, CLO and OAC. The Rotherham Hospital database holds details of all GORD, CLO and OAC patients seen in the Gastroenterology Unit. Blood group information for patients with GORD was obtained from patients' records and the hospital's blood transfusion service. The blood group distribution in the general population was obtained from the National Blood Transfusion Service. The number of expected to observed patients in each blood group for each subtype was compared.
RESULTS: Two thousand six hundred and ten NER, 2813 erosive oesophagitis, 568 CLO and 73 OAC patients had a recorded blood group. For RhD positive patients observed proportions in each blood group were similar to expected. The most striking difference was the marked excess of OAC in blood group O, Rhesus negative (P=0.002).
CONCLUSION: CLO patients with blood group O, RhD negative carry a disproportionately higher risk of developing OAC. The mechanism is unknown but the finding has practical application in guiding risk stratification and intensity of surveillance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21701391     DOI: 10.1097/MEG.0b013e3283489dcf

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  9 in total

1.  Barrett esophagus: Blood group linked to risk of cancer in patients with Barrett esophagus.

Authors:  Rachel Thompson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-09-02       Impact factor: 46.802

2.  Do AB0 blood groups affect lower urinary tract symptoms?

Authors:  Erdal Benli; Abdullah Çırakoğlu; Ercan Öğreden; Yasemin Kaya; Ali Ayyıldız; Ahmet Yüce
Journal:  Turk J Urol       Date:  2018-11-19

3.  Heartburn, Barrett's oesophagus and cancer: implications for primary care.

Authors:  Anthony Watson; John Galloway
Journal:  Br J Gen Pract       Date:  2014-03       Impact factor: 5.386

4.  The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy.

Authors:  Oliver Engel; Armin Soave; Sven Peine; Luis A Kluth; Marianne Schmid; Shahrokh F Shariat; Roland Dahlem; Margit Fisch; Michael Rink
Journal:  World J Urol       Date:  2015-03-18       Impact factor: 4.226

5.  Is there a predictive significance of ABO blood group on chemotherapy-induced thrombocytopenia in patients with stage III colon cancer?

Authors:  Ozgur Tanriverdi
Journal:  Med Oncol       Date:  2014-11-27       Impact factor: 3.064

Review 6.  Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review).

Authors:  Abbas Salihi; Mohammed A Al-Naqshabandi; Zhikal Omar Khudhur; Zjwan Housein; Harmand A Hama; Ramyar M Abdullah; Bashdar Mahmud Hussen; Twana Alkasalias
Journal:  Mol Med Rep       Date:  2022-05-26       Impact factor: 3.423

7.  ABO blood type, long-standing diabetes, and the risk of pancreatic cancer.

Authors:  Naoto Egawa; Yingsong Lin; Taku Tabata; Sawako Kuruma; Seiichi Hara; Ken Kubota; Terumi Kamisawa
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

8.  Allele frequency of ABO blood group antigen and the risk of esophageal cancer.

Authors:  Narender Kumar; Akhil Kapoor; Ashok Kalwar; Satya Narayan; Mukesh Kumar Singhal; Akhender Kumar; Abhishek Mewara; Megh Raj Bardia
Journal:  Biomed Res Int       Date:  2014-06-19       Impact factor: 3.411

9.  ABO and Rhesus blood groups and risk of endometriosis in a French Caucasian population of 633 patients living in the same geographic area.

Authors:  Bruno Borghese; Mélanie Chartier; Carlos Souza; Pietro Santulli; Marie-Christine Lafay-Pillet; Dominique de Ziegler; Charles Chapron
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.